当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 利润表

南京医药

(600713)

4.25

0.04  (0.95%)

今开:4.22最高:4.26成交:2.47万手 市盈:0.00 上证指数:2939.62   0.05%2019-10-21
昨收:4.21 最低:4.17 换手:0.00%振幅:0.00 深证指数:9553.57  0.21%15:02:41

集合

竞价

利润表

按照会计年度查询:
报告期2019-06-302018-12-312018-09-302018-06-30
一、营业总收入17,914,143,887.9431,303,046,293.3622,595,699,812.3814,767,193,249.31
营业收入17,914,143,887.9431,303,046,293.3622,595,699,812.3814,767,193,249.31
二、营业总成本17,608,623,649.7730,859,466,087.6522,269,006,191.2614,524,317,858.04
营业成本16,733,368,195.7529,235,117,341.621,152,837,585.9813,798,233,519.1
营业税金及附加29,566,153.4565,032,744.9744,965,562.7728,191,733.02
销售费用450,842,538.92824,149,149.48541,006,819.07355,961,727.15
管理费用179,580,149.29371,116,703.77253,971,609.86161,016,641.85
财务费用208,716,709.43347,783,802.07252,857,768.82170,994,349.46
资产减值损失-12,673,165.979,832,796.818,563,216.316,524,117.41
三、其他经营收益22,871,773.5223,645,420.2630,859,151.0956,861,075.91
允许价值变动净收益--------
投资净收益-83,464.57-4,241,523.01105,759.8105,759.8
联营、合营企业投资收益-109,956.97-4,212,795.55105,759.8105,759.8
汇兑净收益--------
四、营业利润286,131,628.16479,731,881.98363,233,192.88244,699,448.76
营业外收入2,238,960.5110,536,510.73916,318.9679,264.35
营业外支出6,933,682.8114,472,222.148,970,633.896,773,034.27
非流动资产处置净损失--------
五、利润总额281,436,905.86475,796,170.57355,178,877.89238,605,678.84
所得税75,126,132.97129,964,181.81103,749,563.7264,692,414.93
未确认的投资损失--------
六、净利润(百万元)159.7472.19264.29197.48
少数股东损益46,573,714.0181,538,206.153,946,944.9935,115,480.89
归属于母公司股东的净利润159,737,058.88264,293,782.66197,482,369.18138,797,783.02
七、每股收益0.150.260.19--
基本每股收益0.150.260.190.14
稀释每股收益0.150.260.190.14
TOP↑